Author:
Shahab Farhad Mostafavi,Kobarfard Farzad,Dadashzadeh Simin
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference9 articles.
1. Alahari, A., Trivelli, X., Guerardel, Y., Dover, L. G., Besra, G. S., Sacchettini, J. C., Reynolds, R. C., Coxon, G. D., and Kremer, L., Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. PLoS ONE, 2, e1343 (2007).
2. Bermudez, L. E., Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice. Antimicrob. Agents Chemother., 47, 2685–2687 (2003).
3. Cock, K. M. D. and Chaisson, R. E., Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int. J. Tuberc. Lung Dis., 3, 457–465 (1999).
4. Duncan, K., Progress in TB drug development and what is still needed. Tuberculosis (Edinb)., 83, 201–207 (2003).
5. Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., and Dye, C., Tuberculosis. Lancet, 362, 887–899 (2003).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献